This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: China Medical University Hospital, The University of North Carolina at Chapel Hill. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 21 
1 out of 1,327 
Years Active: 2017
Title: Yong-Long Zhao: Innovator in Antitumor Agents
Introduction
Yong-Long Zhao is a notable inventor based in Chengdu, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumor agents. His innovative work focuses on synthesizing novel compounds that can potentially treat various types of cancer.
Latest Patents
Yong-Long Zhao holds a patent for novel 20-sulfonylamidine derivatives of camptothecin. This invention includes a method of synthesizing these derivatives and their use as antitumor agents. Specifically, these compounds are aimed at treating nasopharyngeal, lung, breast, or prostate cancer.
Career Highlights
Throughout his career, Yong-Long Zhao has worked with prestigious institutions such as China Medical University Hospital and the University of North Carolina at Chapel Hill. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Yong-Long Zhao has collaborated with esteemed colleagues, including Kuo-Hsiung Lee and Keduo Qian. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Yong-Long Zhao is a prominent figure in the field of antitumor research, with a focus on innovative compounds that hold promise for cancer treatment. His contributions continue to influence the development of effective therapies for various cancers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile